Published :
Tables : 54
Figures : 52
Category : Healthcare
No. of Pages : 215
Report Code : HC-1326
Antiseptic and Disinfectant Market Introduction: Antiseptic and Disinfectant Market is estimated to value over USD 90 billion by 2028 end at a CAGR of over 20% during the forecast period 2021 to 2028. Disinfectants and antiseptic are products which are used to prevent the rise of microorganisms when it interacts with an inanimate object or living tissue. An antiseptic is a chemical element which takes control over the growth of microorganisms and a disinfectant is a chemical element that keeps infections at bay by disintegrating micro-organisms that are harmful. There are many advantages associated with disinfectants and antiseptic that include affordability, stability with chemicals and lack of staining with acceptable odor and colour. Disinfectants and antiseptics are used in hospital settings for an array of varied hard surface and topical applications. The antiseptic and disinfectant market growth can be credited the boost in healthcare expenditure, curating innovative healthcare amenities, the surge of hospital related infections and the rise in hygiene maintenance on a global scale. In addition, there are also other components within this market such as the rising use of endoscope reprocessors as well as surgical units containing disinfected sprayers that are automated. Given all these factors, the market is expected to encounter a revitalized economic boost. However, the strict regulatory bodies may pose potential threats to the global market for antiseptic and disinfectant during the forecast timeline. Going by the segmentation of the product, the market is bifurcated into iodine, alcohols, hydrogen peroxide, silver, chlorine compounds, phenolic compounds, aldehydes, quaternary ammonium compounds and others. Phenolic and aldehydes compounds are projected to grow at an exponential rate. In the case of phenolic compounds, there are a number of advantages associated with it in comparison to hydrogen peroxide. In terms of the end user, the is divided into domestic users, healthcare providers and commercial users. The healthcare providers are likely to take control of the market and acquire significant market share. A great deal of utilization of medical instruments, the rise of hospital-related infections, and a surge in the healthcare expenditure in terms of the per capita income in both developed and developing companies alike, are among the components which are anticipated to expand the antiseptic and disinfectant market size. In addition, commercial users of this particular market may further catalyze the industry growth during the forecast time frame because of the effectiveness against bacteria that is vegetative and the associated fungi and viruses. Major players included in the Antiseptic and Disinfectant Market: • 3M Company • Novartis Ag • Johnson & Johnson • Steris Plc • Getinge Group • Cardinal Health • Becton Dickinson And Company • Whiteley Corporation • Kimberly-Clark • Reckitt Benckiser Group Plc • Bio-cide International, Inc • Johnson & Johnson Services, Inc (Note: The list of the major players will be updated with the latest market scenario and trends) Antiseptic and Disinfectant Market Segmentation: By Type • Quaternary Ammonium Compounds • Chlorine Compounds • Alcohols • Aldehydes • Phenolic Compounds • Hydrogen Peroxide • Iodine • Silver • Others By Product • Enzymatic Cleaners • Medical Device Disinfectants • Surface Disinfectants By End-Use • Hospitals • Clinics • Others By Sales Channel • B2B • FMCG By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the Antiseptic and Disinfectant Market By Type, By Product, By End Use, By Sales Channel, and By Region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Antiseptic and Disinfectant Market is estimated to value over USD 90 billion by 2028 end at a CAGR of over 20% during the forecast period 2021 to 2028.
Disinfectants and antiseptic are products which are used to prevent the rise of microorganisms when it interacts with an inanimate object or living tissue. An antiseptic is a chemical element which takes control over the growth of microorganisms and a disinfectant is a chemical element that keeps infections at bay by disintegrating micro-organisms that are harmful. There are many advantages associated with disinfectants and antiseptic that include affordability, stability with chemicals and lack of staining with acceptable odor and colour. Disinfectants and antiseptics are used in hospital settings for an array of varied hard surface and topical applications.
The antiseptic and disinfectant market growth can be credited the boost in healthcare expenditure, curating innovative healthcare amenities, the surge of hospital related infections and the rise in hygiene maintenance on a global scale. In addition, there are also other components within this market such as the rising use of endoscope reprocessors as well as surgical units containing disinfected sprayers that are automated. Given all these factors, the market is expected to encounter a revitalized economic boost. However, the strict regulatory bodies may pose potential threats to the global market for antiseptic and disinfectant during the forecast timeline.
Going by the segmentation of the product, the market is bifurcated into iodine, alcohols, hydrogen peroxide, silver, chlorine compounds, phenolic compounds, aldehydes, quaternary ammonium compounds and others. Phenolic and aldehydes compounds are projected to grow at an exponential rate. In the case of phenolic compounds, there are a number of advantages associated with it in comparison to hydrogen peroxide.
In terms of the end user, the is divided into domestic users, healthcare providers and commercial users. The healthcare providers are likely to take control of the market and acquire significant market share. A great deal of utilization of medical instruments, the rise of hospital-related infections, and a surge in the healthcare expenditure in terms of the per capita income in both developed and developing companies alike, are among the components which are anticipated to expand the antiseptic and disinfectant market size. In addition, commercial users of this particular market may further catalyze the industry growth during the forecast time frame because of the effectiveness against bacteria that is vegetative and the associated fungi and viruses.
Major players included in the Antiseptic and Disinfectant Market: • 3M Company • Novartis Ag • Johnson & Johnson • Steris Plc • Getinge Group • Cardinal Health • Becton Dickinson And Company • Whiteley Corporation • Kimberly-Clark • Reckitt Benckiser Group Plc • Bio-cide International, Inc • Johnson & Johnson Services, Inc (Note: The list of the major players will be updated with the latest market scenario and trends)
Antiseptic and Disinfectant Market Segmentation: By Type • Quaternary Ammonium Compounds • Chlorine Compounds • Alcohols • Aldehydes • Phenolic Compounds • Hydrogen Peroxide • Iodine • Silver • Others By Product • Enzymatic Cleaners • Medical Device Disinfectants • Surface Disinfectants By End-Use • Hospitals • Clinics • Others By Sales Channel • B2B • FMCG By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Antiseptic and Disinfectant Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Antiseptic and Disinfectant Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Antiseptic and Disinfectant Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Antiseptic and Disinfectant Market, By Type Historical Analysis and Forecast 2021-2028 (USD Million) 7.1. Quaternary Ammonium Compounds 7.2. Chlorine Compounds 7.3. Alcohols 7.4. Aldehydes 7.5. Phenolic Compounds 7.6. Hydrogen Peroxide 7.7. Iodine 7.8. Silver 7.9. Others 8. Global Antiseptic and Disinfectant Market, By Product Historical Analysis and Forecast 2021-2028 (USD Million) 8.1. Enzymatic Cleaners 8.2. Medical Device Disinfectants 8.3. Others 9. Global Antiseptic and Disinfectant Market, By End Use Historical Analysis and Forecast 2021-2028 (USD Million) 9.1. Hospitals 9.2. Clinics 9.3. Others 10. Global Antiseptic and Disinfectant Market, By Sales Channel Historical Analysis and Forecast 2021-2028 (USD Million) 10.1. B2B 10.2. FMCG 11. North America Antiseptic and Disinfectant Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2021-2028 12. Latin America Antiseptic and Disinfectant Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2021-2028 13. Europe Antiseptic and Disinfectant Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2021-2028 14. Asia Pacific Antiseptic and Disinfectant Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2021-2028 15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2021-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. 3M Company 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Novartis Ag 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Johnson & Johnson 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Steris Plc 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Getinge Group 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Cardinal Health 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Becton Dickinson And Company 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Whiteley Corporation 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Kimberly-Clark 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Reckitt Benckiser Group Plc 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11.Bio-cide International, Inc 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12.Johnson & Johnson Services, Inc 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Global Antiseptic and Disinfectant Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Antiseptic and Disinfectant Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Antiseptic and Disinfectant Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Antiseptic and Disinfectant Market, By Type Historical Analysis and Forecast 2021-2028 (USD Million) 7.1. Quaternary Ammonium Compounds 7.2. Chlorine Compounds 7.3. Alcohols 7.4. Aldehydes 7.5. Phenolic Compounds 7.6. Hydrogen Peroxide 7.7. Iodine 7.8. Silver 7.9. Others
8. Global Antiseptic and Disinfectant Market, By Product Historical Analysis and Forecast 2021-2028 (USD Million) 8.1. Enzymatic Cleaners 8.2. Medical Device Disinfectants 8.3. Others
9. Global Antiseptic and Disinfectant Market, By End Use Historical Analysis and Forecast 2021-2028 (USD Million) 9.1. Hospitals 9.2. Clinics 9.3. Others
10. Global Antiseptic and Disinfectant Market, By Sales Channel Historical Analysis and Forecast 2021-2028 (USD Million) 10.1. B2B 10.2. FMCG
11. North America Antiseptic and Disinfectant Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2021-2028
12. Latin America Antiseptic and Disinfectant Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2021-2028
13. Europe Antiseptic and Disinfectant Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2021-2028
14. Asia Pacific Antiseptic and Disinfectant Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2021-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Saudi Arabia 15.2.2. UAE 15.2.3. South Africa 15.2.4. Egypt 15.3. Market Size (USD Million) Forecast for MEA 2021-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. 3M Company 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Novartis Ag 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Johnson & Johnson 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Steris Plc 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Getinge Group 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Cardinal Health 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Becton Dickinson And Company 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Whiteley Corporation 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Kimberly-Clark 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Reckitt Benckiser Group Plc 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11.Bio-cide International, Inc 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12.Johnson & Johnson Services, Inc 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics